Please select a region
Manage Consent Preferences
Cookie Details
Strictly Functional Cookie
Analytics Cookie
Targeting Cookie
Back
Analytics Cookies
x
Cookies List
Our site is undergoing a scheduled maintenance from 30th December 2020 to 3rd January 2021 and some functionalities will not be available at this time
Loading your cart..
-
Products
Products
-
Services
Services
-
-
Challenges
Challenges
-
Reducing Total Cost of Ownership
Solving the Challenge of High pH Injectable Drug ProductsClick HerePackaging Solutions for Sensitive Molecules
Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
-
-
Support
Support
-
Regulatory SupportWest Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.Regulatory SupportKnowledge CenterThe West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.Knowledge Center
-
Services
Challenges

Solving the Challenge of High pH Injectable Drug Products
Click Here

Solving the Challenge of Single-Use Large-Volume Delivery for Patient Self-Injection
Support
Regulatory Support
West Regulatory Affairs provides a single point of contact to assist with global registration strategies for all West products and processes.
Regulatory Support
Knowledge Center
The West Knowledge Center provides scientific insight and more detailed technical information on key areas of expertise featuring technical reports, bulletins and science posters.
Knowledge Center
- Home
Blog
The West Blog
Latest Post
May 22, 2020
SARS-CoV-2 Vaccines – Primary Packaging Challenges
Developing a SARS-CoV-2 vaccine presents numerous and unprecedented challenges; prominent among them are greatly accelerated timelines. Ordinarily for a new drug product, there is sufficient time for selection/evaluation of the vial/stopper packaging system – one that guarantees quality and safety from manufacture through delivery. This is not the case for a SARS-CoV-2 vaccine where the primary packaging system must be chosen quickly, creating a higher risk.

Page McAndrew PhD.
Director, Scientific Communications
Categories
Search the Blog
Archive
Load more
Loading...
Previous Posts

January 29, 2019
Effective Drug Protection for Plungers in a Prefillable Syringe System

Christa Jansen-Otten
Director, Product Mgmt, PFS & Delivery

February 17, 2012
The Effect of a Barrier Film on Elastomeric Extractables in a Parenteral Packaging System

Amy Miller & Jennifer Riter
Analytical Lab Services